Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PhageGenÔ has established a strong technology base in infectious disease microbiology, bacteriophage biology and viral molecular genetics. The Company has established business and laboratory operations in the United Kingdom, France and the US to focus its resources on targeted business and strategic planning, as well as the implementation of an R&D program that will result in the commercial introduction of products for the treatment of selected bacterial infectious diseases, initially TB, MDRTB, Staphylococcus, Anthrax, Pseudomonas and others. PhageGenÔ considers intellectual property as fundamental to its long-term success, and has adopted a program to identify and protect intellectual property and to characterize, develop and patent novel technologies created within its laboratories. ( www.phagegen.com )
PHAGE GENOMICS, INC
2215 Lucerne Circle
Henderson, Nevada 89104
USA
Tel: (702) 451-4981